Supernus Pharmaceuticals | SUPN - PE Price to Earnings


Supernus Pharmaceuticals reported $39.11 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Abbott USD 30.71 14.41 Dec/2025
ANI Pharmaceuticals USD 98.67 48.54 Sep/2025
Aurora Cannabis CAD 23.27 0 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Corcept Therapeutics USD 94.18 30.36 Sep/2025
Eisai JPY 26.16 4.7 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Novo Nordisk DKK 12.78 0.01 Dec/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Supernus Pharmaceuticals USD 39.11 17.08 Sep/2025
United Therapeutics USD 15.7 4.24 Sep/2025